Triton Financial Group Inc Takes $869,000 Position in The Clorox Company $CLX

Key Points

• Triton Financial Group Inc has acquired a new position in The Clorox Company, purchasing 7,240 shares valued at approximately $869,000 in the second quarter.
• Clorox's recent quarterly earnings showed a profit of $2.87 per share, exceeding analysts' estimates and reflecting a 4.5% increase in year-over-year revenue.
• The company has announced a quarterly dividend of $1.24 per share, representing an annualized dividend yield of 4.1%, payable on November 6th.

Triton Financial Group Inc purchased a new stake in The Clorox Company (NYSE:CLX - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 7,240 shares of the company's stock, valued at approximately $869,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Journey Advisory Group LLC lifted its stake in Clorox by 22.1% during the second quarter. Journey Advisory Group LLC now owns 1,991 shares of the company's stock valued at $239,000 after buying an additional 360 shares in the last quarter. Bogart Wealth LLC increased its position in shares of Clorox by 289.5% in the second quarter. Bogart Wealth LLC now owns 370 shares of the company's stock worth $44,000 after acquiring an additional 275 shares in the last quarter. Canvas Wealth Advisors LLC raised its holdings in shares of Clorox by 190.5% during the second quarter. Canvas Wealth Advisors LLC now owns 29,548 shares of the company's stock valued at $3,760,000 after acquiring an additional 19,377 shares during the period. Stephens Inc. AR lifted its position in shares of Clorox by 32.4% in the 2nd quarter. Stephens Inc. AR now owns 3,778 shares of the company's stock valued at $454,000 after acquiring an additional 924 shares in the last quarter. Finally, Chicago Partners Investment Group LLC boosted its stake in Clorox by 29.7% in the 2nd quarter. Chicago Partners Investment Group LLC now owns 2,514 shares of the company's stock worth $330,000 after purchasing an additional 575 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CLX. Barclays lowered their price objective on shares of Clorox from $118.00 to $112.00 and set an "underweight" rating on the stock in a research report on Tuesday, September 30th. Zacks Research raised Clorox from a "strong sell" rating to a "hold" rating in a research report on Monday, September 29th. JPMorgan Chase & Co. dropped their price target on Clorox from $135.00 to $127.00 and set a "neutral" rating on the stock in a research report on Friday, October 10th. UBS Group reduced their price objective on Clorox from $134.00 to $128.00 and set a "neutral" rating for the company in a research note on Wednesday, October 8th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Clorox in a research note on Tuesday, October 14th. One equities research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Reduce" and an average target price of $130.20.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.63% of the stock is currently owned by company insiders.

Clorox Stock Performance

Shares of NYSE CLX opened at $119.60 on Tuesday. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The business's 50-day moving average price is $121.56 and its two-hundred day moving average price is $127.42. The company has a market capitalization of $14.56 billion, a P/E ratio of 18.34, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business's quarterly revenue was up 4.5% on a year-over-year basis. During the same period last year, the business earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox's payout ratio is currently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.